Fuentes y referencias

Artículo "¿Ha experimentado alguno de estos síntomas?"

  • Boulton A.J., et al., Diabetic somatic neuropathies. Diabetes Care. 2004 Jun;27(6):1458-86.

  • Callaghan B.C., et al., Diabetic neuropathy: Clinical manifestations and current treatments. Lancet Neurol 2012; 11: 521-534.

  • Freynhagen R., et al., painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin2006; 22(10):1911-1920.

  • Landmann G., SIG: Pain, Mind and Movement IV, Diagnosis and treatment of painful polyneuropathy. Psychiatrie & Neurologie, 2012; 5.

  • Miranda-Massari J.R. et al., Metabolic correction in the management of diabetic peripheral neuropathy. Improving clinical results beyond symptom control. Curr Clin Pharmacol. 2011; 6(4): 260-273.

  • Negrão L., et al., Effect of the combination of uridine nucleotides, folic acid and vitamin B12 on the clinical expression of peripheral neuropathies. Pain Management 2014; 4(3), 191–196.

Artículo "Algunos signos pueden ser engañosos, consulte a su médico"

  • Callaghan B.C., et al., Diabetic neuropathy: Clinical manifestations and current treatments. Lancet Neurol 2012; 11: 521-534.

  • Katzberg H.D., Neurogenic muscle cramps. J Neurol (2015) 262:1814–1821.

  • Misra U.K., et al., Diagnostic approach to peripheral neuropathy. Ann Indian Acad Neurol. 2008 Apr-Jun; 11(2): 89–97.

Artículo "Alteraciones de la función de los nervios en grupos de riesgo"

  • Andrès E., et al., VitaminB12 (cobalamin) deficiency in elderly people. CMAJ 2004; 171(3):251-259.

  • Briani C., et al., Cobalamin deficiency: clinical picture and radiological findings. Nutrients 2013, 5, 4521-4539.

  • Callaghan B.C., et al., Distal symmetric polyneuropathy A Review. JAMA 2015; Volume 314, Number 20.

  • Carmel R. and Agrawal Y.P., Failures of cobalamin assays in pernicious anemia. N Engl J Med 2012; 367:385-386.

  • De Rosa A, et al., Subacute combined degeneration of the spinal cord in a vegan. Clin Neurol Neurosurg. 2012 Sep;114(7):1000-1002.

  • Freemann R., Not all neuropathy in diabetes is of diabetic etiology: differential diagnosis of diabetic neuropathy. R. Curr Diab Rep (2009) 9: 423–431.

  • Head K.A., Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Rev. 2006 Dec;11(4):294-329.

  • Holzbach E., Thiamine absorption in alcoholic delirium patients. J Stud Alcohol 1996; 57: 581-584.

  • Kjeldby I.K., et al., Vitamin B6 deficiency and diseases in elderly people--a study in nursing homes. BMC Geriatr. 2013 Feb 8; 13:13.

  • O’Keeffe S.T., Thiamine deficiency in elderly people. Age and Ageing 2000; 29: 99-101.

  • Smith B.H. and Torrance N., Epidemiology of neuropathic pain and its impact on quality of life. Curr Pain Headache Rep 2012; 16:191–198.

  • Spinneker A., et al., Vitamin B6 status, deficiency and its consequences - an overview. Nutr Hosp. 2007;22(1):7-24.

  • Stabler S., Vitamin B12 Deficiency. N Engl J Med 2013; 368:149-160.

Artículo: "¿Cómo funciona el sistema nervioso?"

  • Hildebrand C., et al, Myelinated nerve fibres in the CNS. Prog Neurobiol. 1993 Mar;40(3):319-84.

  • Simons M. and Trotter J., Wrapping it up: the cell biology of myelination. Curr Opin Neurobiol. 2007 Oct;17(5):533-40. Epub 2007 Oct 17.

  • Swenson R.S., Review of clinical and functional neuroscience. 2006, Dartmouth Medical School. 

Artículo: "¿Qué son las vitaminas B?"

  • Adamo A.M., Nutritional factors and aging in demyelinating diseases. Genes Nutr 2014; 9:360.

  • Bender D., B vitamins in the nervous system, Neurochem. Int. 1984; 6(3): 297 321.

  • Bernstein, A. L., Vitamin B6 in clinical neurology. Annals of the New York Academy of Sciences, 1990; 585: 250–260.

  • Dakshinamurti K., Paulose C.S., Viswanathan M., et al., Neurobiology of pyridoxine. Annals of the New York Academy of Sciences 1990;585:128-44.

  • Elmofty D.H. et al., Best practices in the treatment of neuropathic pain. Pain Manage. 2013; 3(6): 475-483.

  • Frye R.E. and Jabbour S.A., Pyridoxine Deficiency. Secondary Pyridoxine Deficiency 2014. http://emedicine.medscape.com/article/124947-overview#showall.

  • Gröber U., et al., Neuroenhancement with Vitamin B12—Underestimated Neurological Significance Nutrients 2013, 5, 5031-5045.

  • Head K.A., Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Res 2006; 11(4):294-329.

  • Negrão L., et al., Effect of the combination of uridine nucleotides, folic acid and vitamin B12 on the clinical expression of peripheral neuropathies. Pain Management 2014; 4(3), 191–196.

  • Singleton C.K. and Martin P.R., Molecular mechanisms of thiamine utilization. Curr Mol Med 2001;1(2):197-207.

  • Spinneker A., et al., Vitamin B6 status, deficiency and its consequences - an overview. Nutr Hosp. 2007;22(1):7-24.

  • Sriram K., et al., Thiamine in nutrition therapy. Nutr Clin Pract 2012;27(1):41-50.

  • Stabler S.P., Vitamin B12 deficiency. New Eng J Med 2013;368(21):2041-2.

  • Zhang M., et al., Methylcobalamin: a potential vitamin of pain killer. Neural Plast 2013;2013:424651.

Artículo: "La importancia de un diagnóstico temprano en el sistema nervioso"

  • Misra U.K. et al., Diagnostic approach to peripheral neuropathy. Ann Indian Acad Neurol. 2008 Apr-Jun; 11(2): 89–97.

  • Mulvey M.R., et al., The role of screening tools in diagnosing neuropathic pain. Pain manag. 2014; 4(3): 233-243.

  • Okada K., et al., Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model. Exp Neurol (2010) Apr;222(2): 191–203.

  • Polydefkis M., et al., The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain (2004), 127 (7): 1606-1615.

  • Vinik A.I., Neuropathy: new concepts in evaluation and treatment. South Med J. 2002;95(1):21-3.

Artículo: "10 datos fascinantes del sistema nervioso"

  • Elmofty D.H., et al., Best practices in the treatment of neuropathic pain. Pain Manage. 2013; 3(6): 475-483.

  • Head K.A., Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Res 2006; 11(4):294-329.

  • Herculano-Houzel S., et al., The elephant brain in numbers. Front. Neuroanat. 2014, 8:46.

  • Hildebrand C., et al., Myelinated nerve fibres in the CNS. Prog Neurobiol. 1993 Mar;40(3):319-84.

  • Mancini F, et al., Whole-body mapping of spatial acuity for pain and touch. Ann Neurol. 2014 Jun;75(6):917-24.

  • Negrão L., et al., Effect of the combination of uridine nucleotides, folic acid and vitamin B12 on the clinical expression of peripheral neuropathies. Pain Management 2014; 4(3), 191–196.

  • Polydefkis M., et al., The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain (2004), 127 (7): 1606-1615.

  • Stabler S.P., Vitamin B12 deficiency. New Eng J Med 2013;368(21):2041-2.

  • Swenson R.S., Review of clinical and functional neuroscience. 2006, Dartmouth Medical School.

Artículo: "Alteraciones en los nervios: Recomendaciones para grupos de riesgo"

  • Callaghan B.C. et al., Diabetic neuropathy: Clinical manifestations and current treatments. Lancet Neurol 2012; 11: 521-534.

  • Dobson J.L. et al., Benefits of exercise intervention in reducing neuropathic pain, Front Cell Neurosci, 2014 Apr.

  • Handsaker J.C., et al., Resistance exercise training increases lower limb speed of strength generation during stair ascent and descent in people with diabetic peripheral neuropathy. Diabet Med. 2016 Jan;33(1):97-104.

  • Head K.A., Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Rev 2006; 11(4):294-329.

  • Huizinga M.M., et al., Painful diabetic neuropathy: A management-centered review. Clinical Diabetes 2007 Jan; 25(1): 6-15.

  • Kluding P.M., et al., The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complications. 2012 Sep; 26(5): 424–429.

  • Landmann G., SIG: Pain, Mind and Movement IV, Diagnosis and treatment of painful polyneuropathy, Psychiatrie & Neurologie, 2012; 5.

  • Streckmann F., et al., Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports Med. 2014 Sep;44(9):1289-304.

Artículo: "Buenos hábitos para personas con molestias en sus nervios"

  • Callaghan B.C., et al., Diabetic neuropathy: Clinical manifestations and current treatments. Lancet Neurol 2012; 11: 521-534.

  • Head K.A., Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Rev 2006; 11(4):294-329.

  • Huizinga M.M., et al., Painful diabetic neuropathy: A management-centered review. Clinical Diabetes 2007 Jan; 25(1): 6-15.

  • Jensen M.P., et al., The impact of neuropathic pain on health-related quality of life. Review and implications. Neurology, 2007; 68:1178–1182.

  • Katzberg H D., Neurogenic muscle cramps. J Neurol 2015; 262:1814–1821.

  • Kluding P.M., et al., The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complications. 2012 Sep; 26(5): 424–429.

  • Narayan K.M., et al., Diabetes — a common, growing, serious, costly, and potentially preventable public health problem. Diab Res and Clin Pract 50 Suppl. 2 (2000) S77–S84.

  • Nicholson B., Differential diagnosis: nociceptive and neuropathic pain. Am J Manag Care. 2006 Jun;12(9 Suppl):S256-62.

  • O’Connor A., Neuropathic pain. Quality-of-life impact, costs, and cost effectiveness of therapy. Pharmacoeconomics, 2009; 27(2), 95–112.

  • Smith B.H. and Torrance N., Epidemiology of neuropathic pain and its impact on quality of life. Curr Pain Headache Rep (2012) 16:191–198.

Artículo "¿Cuándo necesita tratamiento con vitaminas B?"

Artículo "¿Qué sucede cuando se dañan los nervios?"

Artículo "Tratamientos para transtornos nerviosos"

Artículo "10 datos sobre las señales transmitidas por los nervios"

  • Callaghan B.C., et al., Diabetic neuropathy: Clinical manifestations and current treatments. Lancet Neurol 2012; 11: 521-534.

  • Callaghan B.C., et al., Distal symmetric polyneuropathy a Review. JAMA 2015; Volume 314, Number 20.

  • Freynhagen R. and Bennett M.I., Diagnosis and management of neuropathic pain. BMJ 2009; 339:b3002.

  • Head K.A., Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Rev. 2006 Dec; 11(4): 294-329.

Artículo "¿Sabe cómo la diabetes puede afectar a la salud de los nervios?"

  • Lee, C. C., Perkins, B. A., Kayaniyil, S., Harris, S. B., Retnakaran, R., Gerstein, H. C., ... & Hanley, A. J. (2015). Peripheral neuropathy and nerve dysfunction in individuals at high risk for type 2 diabetes: the PROMISE cohort. Diabetes care, 38(5), 793-800.

  • Head, K. A. (2006). Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Alternative medicine review, 11(4).

  • Vinik, A. I., & Mehrabyan, A. (2004). Diabetic neuropathies. Medical Clinics, 88(4), 947-999.

  • Vinik, A. I., Nevoret, M. L., Casellini, C., & Parson, H. (2013). Diabetic neuropathy. Endocrinology and Metabolism Clinics, 42(4), 747-787.

  • U.S. Department of Health and Human Services (2018). Diabetic neuropathy. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/nerve-damage-diabetic-neuropathies/all-content

  • Calderón‐Ospina, C. A., & Nava‐Mesa, M. O. (2020). B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS neuroscience & therapeutics, 26(1), 5-13.

  • Pyram, R., Kansara, A., Banerji, M. A., & Loney-Hutchinson, L. (2012). Chronic kidney disease and diabetes. Maturitas, 71(2), 94-103.

  • Wilding, J. (2014). The importance of weight management in type 2 diabetes mellitus. International journal of clinical practice, 68(6), 682-691.

  • Eliasson, B. (2003). Cigarette smoking and diabetes. Progress in cardiovascular diseases, 45(5), 405-413.

  • Grossman, A., & Grossman, E. (2017). Blood pressure control in type 2 diabetic patients. Cardiovascular diabetology, 16(1), 1-15.

  • Hicks, C. W., & Selvin, E. (2019). Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Current diabetes reports, 19(10), 1-8.

Artículo "¿Qué es la neuropatía periférica?"

  • Head, K. A. (2006). Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Alternative medicine review, 11(4).

  • Calderón‐Ospina, C. A., & Nava‐Mesa, M. O. (2020). B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS neuroscience & therapeutics, 26(1), 5-13.

  • Wilding, J. (2014). The importance of weight management in type 2 diabetes mellitus. International journal of clinical practice, 68(6), 682-691.

  • Callaghan, B. C., Price, R. S., & Feldman, E. L. (2015). Distal symmetric polyneuropathy: a review. Jama, 314(20), 2172-2181.

  • Vinik, A. I., Maser, R. E., Mitchell, B. D., & Freeman, R. (2003). Diabetic autonomic neuropathy. Diabetes care, 26(5), 1553-1579.

  • Lehmann, H. C., Wunderlich, G., Fink, G. R., & Sommer, C. (2020). Diagnosis of peripheral neuropathy. Neurological research and practice, 2(1), 1-7.

  • Aboonq, M. S. (2015). Pathophysiology of carpal tunnel syndrome. Neurosciences Journal, 20(1), 04-09.

  • Streckmann, F., Zopf, E. M., Lehmann, H. C., May, K., Rizza, J., Zimmer, P., ... & Baumann, F. T. (2014). Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports medicine, 44(9), 1289-1304.

  • Lee, C. C., Perkins, B. A., Kayaniyil, S., Harris, S. B., Retnakaran, R., Gerstein, H. C., ... & Hanley, A. J. (2015). Peripheral neuropathy and nerve dysfunction in individuals at high risk for type 2 diabetes: the PROMISE cohort. Diabetes care, 38(5), 793-800.